Verici Dx (LON:VRCI) Shares Down 8.6% – Here’s Why

Verici Dx plc (LON:VRCI)’s stock price dropped 8.6% during trading on Wednesday . The company traded as low as GBX 0.45 and last traded at GBX 0.48. Approximately 2,220,681 shares changed hands during trading, an increase of 50% from the average daily volume of 1,484,795 shares. The stock had previously closed at GBX 0.53.

Verici Dx Price Performance

The company has a current ratio of 0.91, a quick ratio of 8.49 and a debt-to-equity ratio of 11.36. The firm has a market cap of £7.19 million, a price-to-earnings ratio of -0.16 and a beta of 1.52. The firm’s 50 day simple moving average is GBX 0.61 and its two-hundred day simple moving average is GBX 0.70.

About Verici Dx

Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.